12:00 AM
 | 
Aug 03, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

CAM2029 regulatory update

The EC granted Orphan Drug designation for CAM2029 to treat acromegaly. The long-acting...

Read the full 44 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >